Scott Howard

17PUBLICATIONS
67CO-AUTHORS
Rheumatology and arthritisGene and molecular therapyEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 11, 2026
Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

|Mar 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Jan 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Jul 25, 2025
Retraction Note: New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.

Jesper Heldrup, Archie Bleyer, Laura Ramsey

|Mar 13, 2025
New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.

Jesper Heldrup, Archie Bleyer, Laura Ramsey

|Sep 10, 2024
Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study.

Nicolás Tentoni, Miriam Hwang, Gabriela Villanueva

Pageof 3

Frequent Collaborators

6 joint publications

Miriam Hwang

4 joint publications

Carmelo Rizzari

4 joint publications

Etienne Chatelut

4 joint publications

Stefan Schwartz